Joaquim Ferreira

What have clinical trials taught us about Parkinson’s disease? 2:21
What have clinical trials taught us about Parkinson’s disease?
Joaquim Ferreira • 26 Jun 2022
Learnings from clinical trial failure in Parkinson’s disease 1:52
Learnings from clinical trial failure in Parkinson’s disease
Joaquim Ferreira • 26 Jun 2022
Design of the EPSILON trial of opicapone as an add-on to levodopa in early PD 2:47
Design of the EPSILON trial of opicapone as an add-on to levodopa in early PD
Joaquim Ferreira • 26 Jun 2022
Opicapone: an adjuvant to levodopa in PD therapy 4:28
Opicapone: an adjuvant to levodopa in PD therapy
Joaquim Ferreira • 26 Jun 2022
Appraisal of Huntington’s disease clinical trials 2:50
Appraisal of Huntington’s disease clinical trials
Joaquim Ferreira • 4 Sep 2020
The problems arising in ASO clinical trials and future preparations 3:38
The problems arising in ASO clinical trials and future preparations
Joaquim Ferreira • 4 Sep 2020
Opicapone shows better motor performance in Parkinson’s disease compared to entacapone 3:37
Opicapone shows better motor performance in Parkinson’s disease compared to entacapone
Joaquim Ferreira • 4 Sep 2020
Limitations of pharmacological and surgical treatment for motor fluctuations in Parkinson’s disease 2:00
Limitations of pharmacological and surgical treatment for motor fluctuations in Parkinson’s disease
Joaquim Ferreira • 4 Sep 2020
The content of VJNeurology is intended for healthcare professionals